학술논문

Survival benefit of recombinant human erythropoietin administration prior to onset of end-stage renal disease: Variations across surrogates for quality of care and time
Document Type
Journal
Source
NEPHRON CLINICAL PRACTICE; 2005, 101 2, pC79-pC86, 8p.
Subject
Language
English
ISSN
16602110